MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERS

Multiple-variable dose methods for treating TNFα-related disorders, including Crohn's disease and psoriasis, comprising administering TNFα inhibitors, including TNFα antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction or loading ph...

Full description

Saved in:
Bibliographic Details
Main Authors Taylor Lori K, Hoffman Rebecca S, Peng Joanna Z, Granneman George Richard, Paulson Susan K, Chartash Elliot Keith, Yan Philip
Format Patent
LanguageEnglish
Published 16.02.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Multiple-variable dose methods for treating TNFα-related disorders, including Crohn's disease and psoriasis, comprising administering TNFα inhibitors, including TNFα antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction or loading phase followed by administration of the agent in a maintenance or treatment phase, wherein the TNF-inhibitor is administered in a higher dosage during the induction phase.
Bibliography:Application Number: US201514745092